In the past decade or so, China has been expanding its commitment to scientific research, and it shows. Chinese researchers now produce more scientific publications than U.S.
Scientists working on the frontiers of medicine fear the uproar over the reported births of gene-edited babies in China could jeopardize promising research into how to alter heredity to fend off a variety of disorders. Researchers are rapidly learning how to edit DNA to fight such conditions as Huntington's, Tay-Sachs and hereditary heart disease, conducting legally permissible experiments in lab animals and petri dishes without taking the ultimate step of actually creating babies. Now they worry about a backlash against their work, too.
Higher education R&D expenditures (HERD) grew by 38.9 percent from 2008 to 2017, an increase of more than $21 billion, according to an SSTI analysis of recently released data from the National Science Foundation’s National Center for Science and Engineering Statistics. From 2016 to 2017, HERD grew by $3.8 billion, the largest year-over-year increase since 2010-2011.
A recent report by Ernst & Young documents continued efforts by countries to enact additional tax incentives to reward companies for research and development. The purpose of these incentives is two-fold. Of course, these countries would like to attract more research activity from overseas. But maybe even more important, they want to increase domestic investment from within their own borders.
Since 2011, more than half of the nation's new investment in business research and development has come from California companies, and more than three-quarters has come from the top five states, according to an SSTI analysis of recently released NSF data.
"The beauty of redoing the portfolio -- and I'll use DuPont as the example -- [is] we're going to spend almost $1 billion on R&D per year, so it's at a rate that's very healthy compared to the competitive peer set," Breen told Jim Cramer in an interview.
"The hope with this project is to engage families in engineering and making to empower them to design and build solutions to challenges they face in their homes and communities," said Adam Maltese, principal investigator for the project and associate professor of science education. "Through this, we hope they are exposed to the diverse opportunities that they might pursue with STEM."
Recently, I was honored to be invited by Dr. Robert Boege, Executive Director of ASTRA to join ASTRA’s Futurist Dr. Ronnie Lowenstein, and serve as a NetGeneration of Youth Cyberjournalist covering a Congressional Briefing held in the Rayburn House Office Building on October 11, 2018 entitled, “Ending Opiod Use: A New Hope”. The event was co-sponsored by ASTRA, The World Association for Laser Therapy, NetGeneration of Youth, The Optical Society of America, and thirteen other science and medical organizations. What an opportunity to learn about PBM, “photobiomodulation,” an innovative medical technology, as well as, to be exposed to the organizational stakeholders who advocate for support of America’s ‘science and technology innovation ecosystem.’
A recent report by Ernst Young documents continued efforts by countries to enact additional tax incentives to reward companies for research and development. The purpose is two-fold. Of course these countries would like to attract more research activity from overseas. But maybe even more important, they want to increase domestic investment from within their own borders. There is strong evidence that tax incentives increase both.
Can being in the middle of an opera take your mind off pain? Here at the University of Maryland, scientists are studying the therapeutic value of experiencing a virtual-reality recording of Francis Poulenc’s “Dialogues of the Carmelites.” The hope is that, at least in some situations, the distraction of an immersive virtual experience can provide pain relief without having to turn to opioids.